Why is Tilray (TSX: TLRY) stock falling despite rapid expansion?

Published on February 23, 2022 11:33 AM EST

Why is Tilray (TSX: TLRY) stock falling despite rapid expansion? — Image source: © 2022 Kalkine Media Inc

Highlights

Tilray Inc (TSX:TLRY) is creating a buzz on the stock markets following some recent developments in its cannabis business.

Its stocks, however, plummeted was down by about four per cent at market close on Tuesday, February 22, despite this announcement.

The cannabis company saw its net revenue grow 20 per cent year-over-year (YoY) to US$ 155 million in Q2 FY2022.

Tilray Inc (TSX: TLRY) is creating a buzz on the stock markets following some recent developments in its cannabis business.

Its stocks, however, plummeted was down by about four per cent at market close on Tuesday, February 22, despite this announcement.

Before looking into its stock health, let us talk about Tilray’s financial performance in Q2 FY2022.

Tilray Inc (TSX: TLRY) financial performance in Q2 FY2022

The cannabis company saw its net revenue grow 20 per cent year-over-year (YoY) to US$ 155 million in Q2 FY2022.

Tilray also saw its second-quarter net profit improve notably to US$ 5.79 million in fiscal 2022, as compared to a loss of US$ 89.24 million a year ago.

Tilray, in January this year, announced the expansion of its medical cannabis footprints in Australia. In addition, it launched a medical cannabis e-learnings platform for healthcare professionals in Australia and new Zealand to enhance their knowledge about medical cannabis usage.

The C$ 3-billion market cap cannabis producer, on February 8, launched a global medical platform named Tilray Medical to consolidate Tilray and Aphria’s medical businesses in order to serve patients with broader access to its medical cannabis brands and products.

On February 9, the company stated that its subsidiary, SweetWater Brewing Company, has expanded in California with Reyes Beer Division as its distributor.

Also read: HIVE & Hut 8 (HUT): 2 Canadian crypto stocks to bag in 2022

On February 22, SweetWater said it plans to continue its westward expansion in California by entering Washington and Oregon with Columbia Distributing as a distributor.

Tilray Brands launched its Good Manufacturing Practice (GMP)-certified medical cannabis products in Malta, Europe, on February 17.

Tilray Brands (TSX:TLRY) stock performance

Tilray stock closed at C$ 7.79 per share on Tuesday, noting a daily trade volume of 1.37 million. The pot stock climbed about seven per cent in the past one month.

The cannabis stock gained almost three per cent in the pre-market hours on Wednesday, February 23, at 8:17AM EST.

Also read: How is Bombardier (TSX: BBD.B) stock doing?

Bottomline

Some experts believe that Tilray stock is struggling despite the rapid expansion of its cannabis footprints mainly due to the prevailing market conditions and economic factors like inflation.

However, considering its business expansion and growth strategies, Tilray could eventually turn into a major player in the cannabis world. Nonetheless, investors should mind the market environment and their risk capacity while making any investment decision.

Kajal Jain

Author

Kajal Jain - Analyst
623 Posts
Kajal is a commerce graduate with expertise in the financial corporate sector. At Kalkine, she writes on Canadian equities and markets. In her free time, she enjoys music and gardening and likes to travel....
Shreya Biswas

Editor

Shreya Biswas - Multimedia Journalist
408 Posts
Shreya Biswas is a multimedia journalist with a degree from the Asian College of Journalism. Previously a literature student-turned-political reporter, she now writes on market trends at Kalkine Media. When not chasing deadlines, she enjoys bloggin...

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.